Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Shock therapy bracelet zaps nausea after surgery

NCT ID NCT06241547

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a wearable bracelet that delivers mild electrical stimulation to a point on the wrist (PC6) to prevent nausea and vomiting after laparoscopic surgery. 326 women participated, and the bracelet was used alongside standard anti-nausea drugs. The goal was to see if adding this device reduces nausea in the first 24 hours after surgery.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
electrical stimulation via EmeTerm bracelet
What this could lead to
If it works, this could offer a non-drug way to prevent nausea and vomiting after surgery, reducing reliance on antiemetic medications.
What could go wrong
This is a single, completed Phase 2 trial with 326 women. The effect may be modest or not better than standard drugs, and results may not apply to men or other surgeries.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 2

Tests whether the treatment actually works, and watches for side effects, in a larger group.

Participants

326 people

The number who actually took part.

Started

Feb 2024

Finished

May 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Patients aged 18-65 years; 2. Patients undergoing elective laparoscopic surgery; 3. American Society of Anaesthesiologists(ASA) Grade 1 to 3; 4. Anesthesia: General Anesthesia, Tracheal Intubation; 5. BMI: ≥18, \<28; 6. Gender: female 7. Patients or their family members are able to comprehend the study protocol and are willing to participate in this research by providing written informed consent. Exclusion Criteria: 1. There are incisions or scars in the wearing position of the device; 2. There is a local infection in the wearing position of the device; 3. upper extremity nerve injury; 4. history of spinal cord surgery; 5. Participated in other clinical trials within 4 weeks; 6. suffering from severe central nervous system disease or mental disorder; 7. Patients need to return to the ICU after surgery.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Postoperative nausea and vomiting are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Postoperative Nausea and Vomiting

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Peking Union Medical College Hospital

    Beijing, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.